Less nocturnal confirmed ( 3.9 mmol/L [ 70 mg/dL ] ) or severe hypoglycemia was observed with Gla-300 from week 9 to month 6 ( relative risk 0.77 [ 95 % CI 0.61-0 .99 ] ; P = 0.038 ) and during the first 8 weeks .